Humanoid Raises $152 Million, Becomes U.K. Robotics Unicorn
U.K. robotics startup Humanoid raises $152 million in Series A funding. Humanoid now has a valuation of $1.35 billion, making it the U.K.’s very first AI robotics unicorn. Prime Movers Lab, a U.S. venture capital firm, led the funding round.
The new round of funding brings Humanoid’s total funding to $270 million since its 2024 inception. The milestone marks Europe’s emergence as a major player in physical artificial intelligence and shows that European robotics companies can scale quickly to directly compete with their counterparts around the globe.
Building Physical AI for Industrial Work
HMND 01 Industrial Wheeled Robot. Image Credit: Humanoid
Humanoid focuses on developing a range of purpose-built, wheel-driven robots, specifically designed for complex factory environments. The company says it’s emphasizing wheeled mobility with the development of a platform that provides better stability, speed and heavy payloads on industrial floors, unlike traditional bipedal humanoids that are dedicated to walking on two feet.
The core of its technical ecosystem is KinetIQ, a proprietary physical artificial intelligence framework. Operating as the robot’s central brain, KinetIQ processes sensor data in real time to allow precise spatial reasoning.
This enables the machines to navigate busy work floors and perform intricate assembly tasks safely alongside human workers without heavy physical barriers. By tightly integrating proprietary hardware with native AI software, Humanoid addresses growing labor shortages across global manufacturing, logistics, and retail distribution centers.
More Updates: Microsoft To Fund Mistral’s European AI Expansion
Commercial Traction and Key Partnerships
Series A Funding Announcement. Image Credit: Humanoid
The company’s billion-dollar valuation stems from swift commercial progress and high-profile industry partnerships. Humanoid has already formed strategic software and hardware alliances with major global technology leaders, including NVIDIA, SAP, Siemens, and Bosch.
Most impressively, the startup recently signed what stands as the industry’s largest publicly announced commercial agreement with motion technology giant Schaeffler. Under this multi-year partnership,
Schaeffler will deploy thousands of Humanoid’s wheeled robots across its global manufacturing plants. Investors consider this massive deployment a clear signal that general-purpose industrial robotics is moving rapidly out of research laboratories and directly onto active production lines.
Founder and Chief Executive Officer Artem Sokolov emphasized that transforming advanced physical AI into practical everyday industrial tools required intense execution speed from a dedicated engineering team.
By blending Europe’s rich industrial heritage with cutting-edge artificial intelligence, Humanoid enters its next development phase poised to redefine global industrial productivity for decades to come.
More Updates: Ant International Raises $1.2B For Global Scaling
Humanoid To Scale Production and Global Reach
The new capital will help Humanoid scale its operational infrastructure and expand research facilities to boost manufacturing. Humanoid currently employs more than 250 engineers and roboticists. It has offices in London, Boston, Vancouver and San Diego.
With the new funding, Humanoid will push the commercial rollout of Beta-version robots to select enterprise customer facilities in Q4. Humanoid also plans to initiate full-scale mass production of its wheeled robots.
Scaling manufacturing this early will help Humanoid establish strong market dominance in industrial automation. The startup will also look to enter general-purpose robotics. The funding is impressive because most physical AI investments have been concentrated in the United States and China.
Humanoid’s impressive trajectory proves that the U.K. and broader European startup ecosystems can build world-class, commercially viable robotics companies.
More Updates: Natural Raises $30M to Build Payments Infrastructure for AI Agents
